Startups

Biorce logo

Biorce

Biorce develops Aika, an AI-native operating system for clinical trial development used by pharmaceutical, biotechnology and clinical research teams. The platform combines clinical-domain data and AI across protocol design, trial simulation, feasibility, contracts and budgets, site activation, eligibility, data and regulatory documentation. It integrates with existing enterprise workflows to generate and continuously update clinical documents, while preserving traceable reasoning and review by qualified human experts. The company aims to reduce avoidable protocol amendments and the time and cost involved in bringing new treatments to patients.

Team

Clara BernardesCo-Founder & Chief Scientific Officer
Lynn Caroline BroekerPR & Media collaborations
Magda KurtzSr Director of Clinical Solutions – Europe
Pedro CoelhoFounder & CEO

Investments

$52M2026-02-02Endeavor Catalyst
$—Unknown dateYZR Capital